Literature DB >> 23078881

Distribution of macrophage polarization markers in human atherosclerosis.

J Lauran Stöger1, Marion J J Gijbels, Saskia van der Velden, Marco Manca, Chris M van der Loos, Erik A L Biessen, Mat J A P Daemen, Esther Lutgens, Menno P J de Winther.   

Abstract

OBJECTIVE: Macrophages are decisive in the chronic inflammatory processes that drive atherogenesis. The purpose of this study was to explore the presence and spatial distribution of polarized macrophage populations in human atherosclerosis. METHODS &
RESULTS: We used transcriptomics and immunohistochemistry to analyze macrophage subset dynamics in successive stages of atherogenesis. Developing lesions progressively accumulated both M1 and M2 cells, as was signified by the enhanced expression of associated markers at the transcriptional and protein level. Histologically, these markers were confined to overlapping, but spatially distinct CD68(+) areas of the intima. We subsequently quantified the presence of these markers in relation to morphological determinants of plaque stability. In line with their pro-inflammatory characteristics, M1 macrophages dominated the rupture-prone shoulder regions of the plaque over M2 polarized cells, while the fibrous caps of lesions showed no significant differences between subsets. In contrast, vascular adventitial tissue displayed a pronounced M2 activation profile. As expected, areas of intraplaque hemorrhage clearly associated with CD163 staining. Rather than being limited to complicated lesions, this M2 marker was also readily detectable in stable plaques. Finally, foamy macrophages displayed an ambiguous repertoire that incorporates individual M1 and M2 markers.
CONCLUSION: M1 and M2 macrophage populations are present throughout atherogenesis. These subsets display disparity when it comes to their prevalence in morphological compartments of the vessel wall. Our current findings warrant continued investigation into the functional implications of polarized macrophage populations in human atherosclerosis.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23078881     DOI: 10.1016/j.atherosclerosis.2012.09.013

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  195 in total

1.  Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses.

Authors:  Veronica Herías; Erik A L Biessen; Cora Beckers; Dianne Delsing; Mengyang Liao; Mat J Daemen; Christine C T N Pham; Sylvia Heeneman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-13       Impact factor: 8.311

Review 2.  Macrophage subsets in atherosclerosis.

Authors:  Giulia Chinetti-Gbaguidi; Sophie Colin; Bart Staels
Journal:  Nat Rev Cardiol       Date:  2014-11-04       Impact factor: 32.419

3.  Differences in forward angular light scattering distributions between M1 and M2 macrophages.

Authors:  David L Halaney; Aydin Zahedivash; Jennifer E Phipps; Tianyi Wang; Jordan Dwelle; Claude Jourdan Le Saux; Reto Asmis; Thomas E Milner; Marc D Feldman
Journal:  J Biomed Opt       Date:  2015-11       Impact factor: 3.170

Review 4.  Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.

Authors:  Mark G MacAskill; David E Newby; Adriana A S Tavares
Journal:  Cardiovasc Res       Date:  2019-12-01       Impact factor: 10.787

5.  M1 Macrophage-Induced Endothelial-to-Mesenchymal Transition Promotes Infantile Hemangioma Regression.

Authors:  Keith Q Wu; Christopher S Muratore; Eui-Young So; Changqi Sun; Patrycja M Dubielecka; Anthony M Reginato; Olin D Liang
Journal:  Am J Pathol       Date:  2017-07-12       Impact factor: 4.307

6.  Modulation of macrophage phenotype by cell shape.

Authors:  Frances Y McWhorter; Tingting Wang; Phoebe Nguyen; Thanh Chung; Wendy F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

7.  An association between mitochondria and microglia effector function. What do we think we know?

Authors:  G Jean Harry; Gabrielle Childers; Sahana Giridharan; Irisyunuel Lopez Hernandes
Journal:  Neuroimmunol Neuroinflamm       Date:  2020-06-16

Review 8.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

9.  Complement protein C1q promotes macrophage anti-inflammatory M2-like polarization during the clearance of atherogenic lipoproteins.

Authors:  Weston Spivia; Patrick S Magno; Patrick Le; Deborah A Fraser
Journal:  Inflamm Res       Date:  2014-08-05       Impact factor: 4.575

10.  Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection.

Authors:  Iftach Shaked; David B Hanna; Christian Gleißner; Brenda Marsh; Jill Plants; Daniel Tracy; Kathryn Anastos; Mardge Cohen; Elizabeth T Golub; Roksana Karim; Jason Lazar; Vinayaka Prasad; Phyllis C Tien; Mary A Young; Alan L Landay; Robert C Kaplan; Klaus Ley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-03-20       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.